Coalition Statement – DTC Advertising:
Recent news coverage regarding a Harvard Medical School study showing correlation between Plavix price increases for Medicaid programs in 27 states and direct-to-consumer advertising costs is unfounded. As study authors concluded, DTC advertising was not associated with an increase in Plavix use above preexisting trends.
Read more
Highlights, commentary and analysis of the November 12th and 13th testimony at the FDA’s Public Hearing on the Internet and Social Media:
Read more
In his Drug Wonks blog, Peter Pitts wrote the following overview of Day 2 of the FDA hearing on social media. He highlighted the diverse views and concerns of witnesses on the subject of “adverse event” reporting and publicity.
Read more
In his Drug Wonks blog Peter Pitts, founder of the Center for Medicine in the Public Interest (CMPI) comments on all the testimony of the first day of the FDA’s Part 15 Hearing on Social Media.
Read more
At the November 12th FDA Public Hearing on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” John Kamp, the Coalition’s Executive Director, presented testimony on behalf of the Coalition and the American Association of Advertising Agencies.
Read more
Recent Comments